Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2030

Antidepressant Trends and Forecast

The future of the global antidepressant market looks promising with opportunities in the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder markets. The global antidepressant market is expected to reach an estimated $21.8 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are rising prevalence of depression, obsessive-compulsive disorder, and other mood disorders across the globe and growing awareness about mental health.

A more than 150-page report is developed to help in your business decisions.

Antidepressant by Segment

The study includes a forecast for the global antidepressant by product, depressive disorder, and region.

Antidepressant Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Tricyclic Antidepressants
• Selective Serotonin Reuptake Inhibitors
• Serotonin-Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Serotonin Antagonist & Reuptake Inhibitors
• Others

Antidepressant Market by Depressive Disorder [Shipment Analysis by Value from 2018 to 2030]:

• Major Depressive Disorder
• Obsessive-Compulsive Disorder
• Generalized Anxiety Disorder
• Panic Disorder
• Others

Antidepressant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Antidepressant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antidepressant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antidepressant companies profiled in this report include-

• Alkermes
• AbbVie
• Eli Lilly
• F. Hoffmann-La Roche
• GlaxoSmithKline
• H. Lundbeck
• Merck

Antidepressant Market Insights

Lucintel forecasts that selective serotonin reuptake inhibitor will remain the largest segment over the forecast period due to rising occurrence of major depressive disorder and anxiety disorders.

Within this market, major depressive disorder will remain the largest segment due to high prevalence of major depressive disorder and increasing awareness towards treatment and management of depression among youth population.

North America will remain the largest region over the forecast period due to increasing cases of depression, surge in the geriatric population, and presence of major players in the region.

Features of the Global Antidepressant Market

Market Size Estimates: Antidepressant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Antidepressant market size by product, depressive disorder, and region in terms of value ($B).

Regional Analysis: Antidepressant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, depressive disorders, and regions for the antidepressant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antidepressant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the antidepressant market size?

Answer: The global antidepressant market is expected to reach an estimated $21.8 billion by 2030.

Q2. What is the growth forecast for antidepressant market?

Answer: The global antidepressant market is expected to grow with a CAGR of 5.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the antidepressant market?

Answer: The major drivers for this market are rising prevalence of depression, obsessive-compulsive disorder, and other mood disorders across the globe and growing awareness about mental health.

Q4. What are the major segments for antidepressant market?

Answer: The future of the antidepressant market looks promising with opportunities in the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder markets.

Q5. Who are the key antidepressant market companies?

Answer: Some of the key antidepressant companies are as follows:

• Alkermes
• AbbVie
• Eli Lilly
• F. Hoffmann-La Roche
• GlaxoSmithKline
• H. Lundbeck
• Merck

Q6. Which antidepressant market segment will be the largest in future?

Answer: Lucintel forecasts that selective serotonin reuptake inhibitor will remain the largest segment over the forecast period due to rising occurrence of major depressive disorder and anxiety disorders.

Q7. In antidepressant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing cases of depression, surge in the geriatric population, and presence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the antidepressant market by product (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist & reuptake inhibitors, and others), depressive disorder (major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?